Lunit AI Used Again for Mass Screening During 2025 Hajj Season in Saudi Arabia

Lunit AI Used Again for Mass Screening During 2025 Hajj Season in Saudi Arabia. Lunit Bahrain Iran Iraq Jordan Kuwait Lebanon Oman Palestine Qatar Saudi Arabia Syria United Arab Emirates Yemen South Korea

in July 2023, with plans to expand across more than 170 medical sites in the Kingdom.

By participating in one of the most logistically demanding health operations in the world, Lunit continues to grow its presence in the Middle East, where the demand for scalable AI tools is rapidly increasing.

###

About Lunit

Founded in 2013, Lunit (KRX:328130.KQ) is a global leader in AI for cancer diagnostics and therapeutics. With a mission to conquer cancer through AI, Lunit develops AI-powered solutions for medical imaging and biomarker analysis to enable precise diagnosis and personalized treatment. Lunit's FDA-cleared Lunit INSIGHT suite supports cancer screening at over 4,800 medical institutions in more than 55 countries. Lunit clinical studies have been featured in top-tier journals—including The Lancet Digital Health and Journal of Clinical Oncology—and presented at major conferences such as ASCO and RSNA. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io.

Logo - https://mma.prnewswire.com/media/1576401/Lunit_CI_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/lunit-ai-used-again-for-mass-screening-during-2025-hajj-season-in-saudi-arabia-302480392.html